The impact of osteoclast activity on dental development has been previously analyzed but in the context of severe osteopetrosis. The present study sought to investigate the effects of osteoclast hypofunction,present in Msx2 gene knockin mutant mice (Msx2–/–), and hyperfunction, in transgenic mice driving RANK over-expression in osteoclast precursors (RANKTg), on tooth development. In Msx2–/– mice, moderate osteopetrosis was observed, occurring exclusively in the periodontal region. Microradiographical and histological analyses revealed an abnormal dental epithelium histogenesis that gave rise to odontogenic tumor-like structures. This led to impaired tooth eruption, especially of the third mandibular molars. In RANKTg mice, root histogenesis showed site-specific upregulation of dental cell proliferation and differentiation rates. This culminated in roots with a reduced diameter and pulp size albeit of normal length. These two reverse experimental systems will enable the investigation of distinctive dental cell and osteoclast communication in normal growth and tumorigenesis.

Keywords:
Bone, Osteoclast, Osteolysis, Osteopetrosis, RANK, Tooth
1.
Aïoub, M., F. Lezot, M. Molla, B. Castaneda, B. Robert, G. Goubin, J.R. Nefussi, A. Berdal (2007) Msx2–/– transgenic mice develop compound amelogenesis imperfecta, dentinogenesis imperfecta and periodental osteopetrosis. Bone 41: 851–859.
2.
Amizuka, N., K. Oda, J. Shimomura, T. Maeda (2002) Biological action of parathyroid hormone (PTH)-related peptide (PTHrP) mediated either by the PTH/PTHrP receptor or the nucleolar translocation in chondrocytes. Anat Sci Int 77: 225–236.
3.
Barbaroux, J.B., M. Beleut, C. Brisken, C.G. Mueller, R.W. Groves (2008) Epidermal receptor activator of NF-kappaB ligand controls Langerhans cells numbers and proliferation. J Immunol 181: 1103–1108.
4.
Berdal, A., A. Nanci, C.E. Smith, J.P. Ahluwalia, M. Thomasset, P. Cuisinier-Gleizes, H. Mathieu (1991) Differential expression of calbindin-D 28 kDa in rat incisor ameloblasts throughout enamel development. Anat Rec 230: 149–163.
5.
Castaneda, B., Y. Simon, J. Jacques, E. Hess, Y.W. Choi, C. Blin-Wakkach, C. Mueller, A. Berdal, F. Lézot (2011) Bone resorption control of tooth eruption and root morphogenesis: involvement of the receptor activator of NF-ĸB (RANK). J Cell Physiol 226: 74–85.
6.
Cheng, S.L., J.S. Shao, J. Cai, O.L. Sierra, D.A. Towler (2008) Msx2 exerts bone anabolism via canonical Wnt signaling. J Biol Chem 283: 20505–20522.
7.
Cobourne, M.T., P.T. Sharpe (2010) Making up the numbers: the molecular control of mammalian dental formula. Semin Cell Dev Biol 21: 314–324.
8.
Dougall, W.C., M. Glaccum, K. Charrier, K. Rohrbach, K. Brasel, T. De Smedt, E. Daro, J. Smith, M.E. Tometsko, C.R. Maliszewski, A. Armstrong, V. Shen, S. Bain, D. Cosman, D. Anderson, P.J. Morrissey, J.J. Peschon, J. Schuh (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13: 2412–2424.
9.
Grigoriadis, A.E., Z.Q. Wang, M.G. Cecchini, W. Hofstetter, R. Felix, H.A. Fleisch, E.F. Wagner (1994) c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266: 443–448.
10.
Heinrich, J., S. Bsoul, J. Barnes, K. Woodruff, S. Abboud (2005) CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption. Arch Oral Biol 50: 897–908.
11.
Helfrich, M.H. (2005) Osteoclast diseases and dental abnormalities. Arch Oral Biol 50: 115–122.
12.
Hotton, D., J.L. Davideau, J.F. Bernaudin, A. Berdal (1995) In situ hybridization of calbindin-D 28 k transcripts in undecalcified sections of the rat continuously erupting incisor. Connect Tissue Res 32: 137–143.
13.
Kim, N., P.R. Odgren, D.K. Kim, S.C. Marks, Jr., Y. Choi (2000) Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Natl Acad Sci USA 97: 10905–10910.
14.
Kong, Y.Y., H. Yoshida, I. Sarosi, H.L. Tan, E. Timms, C. Capparelli, S. Morony, A.J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C.R. Dunstan, D.L. Lacey, T.W. Mak, W.J. Boyle, J.M. Penninger (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315–323.
15.
Lallemand, Y., M.A. Nicola, C. Ramos, A. Bach, C.S. Cloment, B. Robert (2005) Analysis of Msx1; Msx2 double mutants reveals multiple roles for Msx genes in limb development. Development 132: 3003–3014.
16.
Lezot, F., B. Thomas, S.R. Greene, D. Hotton, Z.A. Yuan, B. Castaneda, A. Bolanos, M. Depew, P. Sharpe, C.W. Gibson, A. Berdal (2008) Physiological implications of DLX homeoproteins in enamel formation. J Cell Physiol 216: 688–697.
17.
Li, J., I. Sarosi, X.Q. Yan, S. Morony, C. Capparelli, H.L. Tan, S. McCabe, R. Elliott, S. Scully, G. Van, S. Kaufman, S.C. Juan, Y. Sun, J. Tarpley, L. Martin, K. Christensen, J. McCabe, P. Kostenuik, H. Hsu, F. Fletcher, C.R. Dunstan, D.L. Lacey, W.J. Boyle (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97: 1566–1571.
18.
Liu, D., S. Yao, F. Pan, G.E. Wise (2005) Chronology and regulation of gene expression of RANKL in the rat dental follicle. Eur J Oral Sci 113: 404–409.
19.
Lu, X., H.F. Rios, B. Jiang, L. Xing, R. Kadlcek, E.M. Greenfield, G. Luo, J.Q. Feng (2009) A new osteopetrosis mutant mouse strain (ntl) with odontoma-like proliferations and lack of tooth roots. Eur J Oral Sci 117: 625–635.
20.
Marks, S.C., Jr. (1981) Tooth eruption depends on bone resorption: experimental evidence from osteopetrotic (ia) rats. Metab Bone Dis Relat Res 3: 107–115.
21.
Mitchell, C.A., J.G. Kennedy, R.G. Wallace (1990) Dental abnormalities associated with familial expansile osteolysis: a clinical and radiographic study. Oral Surg Oral Med Oral Pathol 70: 301–307.
22.
Molla, M., V. Descroix, M. Aïoub, S. Simon, B. Castaneda, D. Hotton, A. Bolanos, Y. Simon, F. Lezot, G. Goubin, A. Berdal (2010) Enamel Protein Regulation and Dental and Periodontal Physiopathology in Msx2 Mutant Mice. Am J Pathol 177: 2516–2526.
23.
Nakajima, Y., H. Shimokawa, K. Terai, H. Onoue, Y. Seino, H. Tanaka, S. Sobue, Y. Kitamura, S. Nomura (1996) Identification of the cell type origin of odontoma-like cell masses in microphthalmic (mi/mi) mice by in situ hybridization. Pathol Int 46: 743–750.
24.
Odgren, P.R., N. Kim, C.A. MacKay, A. Mason-Savas, Y. Choi, S.C. Marks, Jr. (2003) The role of RANKL (TRANCE/TNFSF11), a tumor necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescue. Connect Tissue Res 44(suppl 1): 264–271.
25.
Ohazama, A., J.M. Courtney, P.T. Sharpe (2004) Opg, Rank, and Rankl in tooth development: co-ordination of odontogenesis and osteogenesis. J Dent Res 83: 241–244.
26.
Ralston, S.H. (2008) Pathogenesis of Paget’s disease of bone. Bone 43: 819–825.
27.
Satokata, I., L. Ma, H. Ohshima, M. Bei, I. Woo, K. Nishizawa, T. Maeda, Y. Takano, M. Uchiyama, S. Heaney, H. Peters, Z. Tang, R. Maxson, R. Maas (2000) Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 24: 391–395.
28.
Segovia-Silvestre, T., A.V. Neutzsky-Wulff, M.G. Sorensen, C. Christiansen, J. Bollerslev, M.A. Karsdal, K. Henriksen (2009) Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum Genet 124: 561–577.
29.
Tiffee, J.C., L. Xing, S. Nilsson, B.F. Boyce (1999) Dental abnormalities associated with failure of tooth eruption in src knockout and op/op mice. Calcif Tissue Int 65: 53–58.
30.
Tsutsui, T.W., M. Riminucci, K. Holmbeck, P. Bianco, P.G. Robey (2008) Development of craniofacial structures in transgenic mice with constitutively active PTH/PTHrP receptor. Bone 42: 321–331.
31.
Werner, S.A., J. Gluhak-Heinrich, K. Woodruff, Y. Wittrant, L. Cardenas, M. Roudier, M. MacDougall (2007) Targeted expression of csCSF-1 in op/op mice ameliorates tooth defects. Arch Oral Biol 52: 432–443.
32.
Wise, G.E. (2009) Cellular and molecular basis of tooth eruption. Orthod Craniofac Res 12: 67–73.
33.
Yoshino, M., H. Yamazaki, H. Yoshida, S. Niida, S. Nishikawa, K. Ryoke, T. Kunisada, S. Hayashi (2003) Reduction of osteoclasts in a critical embryonic period is essential for inhibition of mouse tooth eruption. J Bone Miner Res 18: 108–116.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.